Daniel Bürgin is a seasoned executive with extensive experience in finance, business development, and corporate growth strategies. With over three decades in the industry, he has demonstrated a remarkable ability to build, scale, and transform businesses. His expertise lies in financial management, investment strategies, and business expansion, which he successfully applied in Tokyo, where he founded a thriving financial services firm that was later acquired by the New York Stock Exchange. As the CEO of T3 BioScience, he leverages his deep understanding of financial markets and strategic leadership to drive the company’s biotech innovations from research to commercial success. His ability to navigate complex financial landscapes and turn innovative ideas into profitable ventures has made him a key player in the biotechnology sector.

Daniel Bürgin’s research focuses on financial strategies, business growth, and market expansion, aiming to bridge the gap between innovation and commercial success in the biotech industry.

• Link 1
• Link 2
• Link 3
• Link 4
• Link 5
• Link 6